Newsfeeds - Spark Newswire

1 minute read

Sera Prognostics Highlights Publication Of PREVENT-PTB Study In American Journal Of Perinatology

Today, 11:05 PM

Sera Prognostics Inc., The Pregnancy Company™, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the

SERA

16 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 9, 2021

By Benzinga Insights

Today, 11:05 PM

Upgrades

AAON

1 minute read

William Blair Initiates Coverage On Sera Prognostics with Outperform Rating

By Benzinga Newsdesk

Today, 11:05 PM

William Blair analyst Brian Weinstein initiates coverage on Sera Prognostics (NASDAQ:SERA) with a Outperform rating.

SERA

1 minute read

Citigroup Initiates Coverage On Sera Prognostics with Buy Rating, Announces Price Target of $18

By Benzinga Newsdesk

Today, 11:05 PM

Citigroup analyst Patrick Donnelly initiates coverage on Sera Prognostics (NASDAQ:SERA) with a Buy rating and announces Price Target of $18.

SERA

1 minute read

Cowen & Co. Initiates Coverage On Sera Prognostics with Outperform Rating

By Benzinga Newsdesk

Today, 11:05 PM

Cowen & Co. analyst Doug Schenkel initiates coverage on Sera Prognostics (NASDAQ:SERA) with a Outperform rating.

SERA

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 11:05 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

5 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:05 PM

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program.

ACY